TSLNC8 serves as a competitive endogenous RNA, attenuating the miR‐10b‐5p inhibitory effect on WWC3, thereby inhibiting the viability, migration and invasion of glioma cells and promoting glioma cell apoptosis. This evidence concerns the gene WWC3 and central nervous system cancer.